Article
The Prognostic Influence of BRAF Mutation and other Molecular, Clinical and Laboratory Parameters in Stage IV Colorectal Cancer.
Pathology oncology research : POR - 1 Oct 2016
Karadima Maria L, Saetta Angelica A, Chatziandreou Ilenia, Lazaris Andreas C, Patsouris Efstratios, Tsavaris Nikolaos
Abstract excerpt
Our aim was to evaluate the predictive and prognostic influence of BRAF mutation and other molecular, clinical and laboratory parameters in stage IV colorectal cancer (CRC). 60 patients were included in this retrospective analysis, and 17 variables were examined for their relation with treatment response and survival. KRAS mutation was identified in 40.3 % of cases, BRAF and PIK3CA in 8.8 % and 10.5 %...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.